It is the case right now, and that's the problem. The public plans balk. They put in very high restrictions in terms of access, so this is the problem. Look at the recommendations coming out. The recommended price they'd be willing to pay is so low. You're asking a company to take a 90% reduction off the proposed price. Companies are not going to do that. In many cases, they won't even come to Canada.
I'm not saying this cannot be done. I'm just saying that, when you have a bulk plan that says, “Fine, we will negotiate, but we expect you to give us a 90% reduction”.... If you read the recommendations coming in and see what's going into the pan-Canadian drug alliance, that is exactly what's happening.
In reality, this is the problem. Ideally, I would love your plan.